lågdoser

Lågdoser is a term used in Swedish to describe small quantities of a substance administered in amounts lower than the standard therapeutic or toxic dose. In pharmacology and medicine, the concept is applied to seek a balance between achieving therapeutic effects and minimizing adverse reactions, particularly in chronic treatments or preventive care. What counts as a low dose varies depending on the substance, the intended effect, and clinical guidelines.

In toxicology and radiobiology, lågdoser are examined for their long-term risk profile and potential non-linear effects. Some substances may show different biological responses at low doses compared with higher doses, a phenomenon discussed in terms of hormesis or threshold models. Others may follow a more linear relationship where any exposure carries some risk. The interpretation of low-dose effects often depends on the specific agent, exposure route, and duration.

Applications and considerations: Low-dose regimens are used to improve tolerability, adherence, and sustained management of conditions, while aiming to preserve efficacy. Examples are highly substance-specific and depend on medical supervision; in some contexts, low-dose regimens are recommended for preventive strategies or maintenance therapy. Outside clinical use, low-dose exposure from environmental or occupational sources is subject to regulation to limit potential harm.

Research and regulation: Dose optimization relies on pharmacokinetic and pharmacodynamic data, as well as safety and efficacy outcomes from trials. Regulatory bodies evaluate low-dose exposures to assess risk, and scientific debates continue about risk at very low doses and the appropriate models to describe dose–response relationships.